Pathway Choice Focus (NY) 5-Year review

It depends on how much you're bringing and where you live. For a New York resident with $100,000 or more to place, this is a good annuity — the rate is competitive, there's no MVA risk, no fees, and the liquidity provisions are reasonable. For someone with less than $100,000, the lower rate band makes it harder to justify against other options. This is not available outside New York, so for the vast majority of the country the question is moot.

The rational case for this annuity is simple: you want a guaranteed rate for five years, you live in New York, and you prefer not to deal with surrender penalties amplified by an MVA. The absence of a market value adjustment means your actual out-of-pocket cost from an early surrender is limited to the stated withdrawal charge schedule — that's a real advantage over MVA-bearing MYGAs in a rising-rate environment. Add in the RMD accommodation and the extended care waiver, and you have a product that's easy to hold for the full term.

I think this annuity is best for a New York resident in the pre-retirement or early retirement phase who has a lump sum of $100,000 or more to set aside for five years. Qualified-account rollovers are a natural fit given the RMD accommodation. It is less attractive for someone who wants any form of index-linked upside, needs ready access to principal beyond 10% per year, or is outside New York. The issue ages run all the way to 90, which is broader than many MYGAs, so it can work for older buyers who simply want principal protection with a guaranteed return.

You are buying a simple interest guarantee. The insurance company takes your premium, guarantees it will earn a fixed annual rate for five years, and returns the accumulated value at the end of the surrender period. There is no indexing, no market participation, no upside beyond the stated rate. That is exactly the point. The value of this product is certainty — you know your rate on day one, you know what you'll have in five years, and nothing between now and then changes that number. For buyers who are weary of rate resets, laddering complexity, or cap uncertainty in FIAs, this kind of locked-rate simplicity is the feature.

The Pathway Choice Focus (NY) 5-Year works by locking your credited rate at contract issue for the full five-year surrender period. The rate you receive depends on your premium size at issue. As of the brochure data (April 2026), the rate tiers are: 3.40% for the low band (under $100,000), 4.25% for the mid band ($100,000 to $249,999), and 4.30% for the upper band ($250,000 and above). An updated rate schedule effective May 11, 2026 brings those tiers to 3.50%, 4.35%, and 4.40% respectively.

Interest compounds annually inside the contract. There is no participation rate, no cap, no spread — just a fixed percentage that accrues each year. The minimum guaranteed surrender value grows at a stated contract rate between 0.15% and 3.00% depending on the contract, which defines the floor if you were to surrender at the worst possible time.

The most practically useful secondary feature is the absence of a market value adjustment. Most MYGAs include an MVA that can increase or decrease your surrender cost depending on where interest rates have moved since you bought the contract. A no-MVA design means the surrender charge schedule is the only cost you face if you need to exit early. In a rising-rate environment — where MVAs tend to work against the policyholder — this is a genuine advantage that's easy to overlook when rate-shopping.

The extended care waiver is also worth noting. After the second contract year, if you need qualifying extended care for 90 or more consecutive days, you can withdraw without the usual surrender charge. The waiver does terminate at owner age 86, so it's most useful for buyers who purchase the contract in their mid-to-late 70s or earlier.

The free-withdrawal provision allows up to 10% of the previous anniversary contract value each year after the first contract year, provided the contract maintains a $2,000 minimum value. This is a standard provision, and for buyers drawing systematic income from the contract it can handle modest distributions without triggering surrender charges.

Required minimum distributions attributable to this contract are permitted at any time after issue without withdrawal charges. That makes this product workable for IRA or qualified rollover money where RMDs are expected.

The surrender schedule declines from 7% in year one to 3% in year five, then drops to zero. There is no MVA, so these percentages represent the full cost of early access above the free amount. An optional return-of-premium guarantee is available at purchase — it ensures you can always get back at least your original premium, but electing it may reduce your initial credited rate.

There are no base contract fees and no rider fees on this product. The cost structure is purely implicit — the spread between what the insurance company earns on your premium and what it credits to you. That is standard for MYGAs and not a reason for concern.

The tradeoffs are structural. The most significant is the rate tier gap: the low band rate (3.40% as of April 2026) is meaningfully lower than the mid and upper tiers, and buyers below $100,000 are getting a noticeably less competitive product. The New York-only restriction also limits this review's practical reach. And like any MYGA, if market rates rise sharply during the five-year period, you are locked in — the product is designed for people comfortable accepting that tradeoff in exchange for certainty.

Legal Entity: The United States Life Insurance Company in the City of New York

Parent: Corebridge Financial, Inc.

A.M. Best Rating: A